A regulatory strategy for a potential and novel iron chelator therapy must be developed regarding orphan drug exclusivity AND pediatric exclusivity in BOTH the US and EU. See specific instructions attached.
A regulatory strategy for a potential and novel iron chelator therapy must be developed regarding orphan drug exclusivity AND pediatric exclusivity in BOTH the US and EU. See specific instructions attached.